SCHEMBL20199774

SCHEMBL20199774

CCN(CC(=O)Oc1ccc([N+](=O)[O-])cc1)C(=O)CN1CCN(CC(=O)OC)CCN(CC(=O)OC)CCN(CC(=O)OC)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL9 O00512 1/20 0.47
CTNNB1 P35222 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 3/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
MGLL Q99685 3/20 0.41
KCNJ1 P48048 2/20 0.41
KCNH2 Q12809 2/20 0.41
GAA P10253 1/20 0.41
ALDH1A1 P00352 3/20 0.41
HRH2 P25021 1/20 0.40
HRH1 P35367 1/20 0.40
PTGS2 P35354 1/20 0.40
FAAH O00519 1/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22403174 0.91 BCL9 (0.48) BCL9CTNNB1SMN1; SMN2MAPTKMT2A
SCHEMBL20189160 0.90 BCL9 (0.47) BCL9CTNNB1SMN1; SMN2MAPTKMT2A
SCHEMBL22112107 0.89 BCL9 (0.43) BCL9CTNNB1SMN1; SMN2MAPTKMT2A
SCHEMBL20200104 0.89 BCL9 (0.42) BCL9CTNNB1SMN1; SMN2MAPTKMT2A
SCHEMBL20199816 0.87 ALDH1A1 (0.50) BCL9CTNNB1SMN1; SMN2MGLLALDH1A1
SCHEMBL20199841 0.85 BCL9 (0.44) BCL9CTNNB1SMN1; SMN2MAPTKMT2A
SCHEMBL20199980 0.83 ACHE (0.41) BCL9CTNNB1SMN1; SMN2MAPTKMT2A
SCHEMBL22112586 0.83 ALDH1A1 (0.47) BCL9CTNNB1SMN1; SMN2MGLLALDH1A1
SCHEMBL20199801 0.82 ACHE (0.42) BCL9CTNNB1SMN1; SMN2MAPTKMT2A
SCHEMBL22403270 0.81 BCL9 (0.42) BCL9CTNNB1SMN1; SMN2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544964-B1 HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING Bayer Pharma AG (DE) 2020-06-17 EP disclosed
WO-2018096082-A1 HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 WO disclosed